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ABSTRACT
Antiphospholipid syndrome (APS) is a multisystemic autoimmune disease which presents with thromboembolic disease, pregnancy
complications and the presence of antiphospholipid antibodies. There are some reports of arterial dissections in different sites of the body
associated with APS. We describe two patients with APS who developed ischaemic stroke as a result of vertebral artery dissection in the
absence of acquired and genetic risk factors for arterial dissection. We also conducted a systematic review of the literature for cases of
arterial dissection associated with APS. We suspect that APS may be a potential cause of vasculopathy and arterial dissection. Further
research is needed to explore this possible association.
LEARNING POINTS
• Antiphospholipid syndrome (APS) is a major risk factor for stroke in young patients.
• APS may be associated with vasculopathy and arterial dissection.
• Patients should meet both clinical and laboratory criteria for a diagnosis of APS.
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INTRODUCTION
Antiphospholipid syndrome (APS) is a multisystemic autoimmune disease with a high predilection for females. APS can be primary or
secondary to other autoimmune disorders such as systemic lupus erythematosus (SLE). The prevalence of the disease is 1–5% in the general
population, but only a small proportion develop symptoms. The clinical manifestations of the disease differ among patients depending on the
location of the vessel and the organ involved. The major presentations of APS include pregnancy-related comorbidities such as recurrent
miscarriage, fetal death, preeclampsia, placental insufficiency and fetal growth restriction, in addition to multiple episodes of arterial,
venous or small vessel thrombosis in different organs or tissues [1, 2].
Antiphospholipid antibodies are circulating immunoglobulins associated with high vascular risk for cardiovascular events that can affect
both arteries and veins. Ischaemic stroke and transient ischaemic attacks are the most commonly described arterial thrombotic events.
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APS is characterized by the presence of circulation antibodies such as lupus anticoagulant (LAC), anti-cardiolipin (aCL), anti-B2 glycoprotein
(A-B2GLP) and anti-prothrombin [3, 4].
A few case reports demonstrate a possible relationship between arterial dissection and APS. In this report, we present two patients with
a previously established diagnosis of APS who presented later with a cerebrovascular accident (CVA) with concurrent vertebral artery
dissection with abrupt onset of neurological sequelae. We also conducted a systematic review of the literature to explore the association
between APS and arterial dissection.
METHODS
A systematic review of the literature was performed to identify cases of arterial dissection of any type and location in patients with APS.
We searched PubMed and Google Scholar using the search terms ‘antiphospholipid syndrome’, ‘aPL’, ‘arterial dissection’, ‘peripheral artery
dissection’, ‘coronary artery dissection’ and ‘dissection’. Studies were included if they were published as original articles, case reports, letters
or meeting abstracts. Review articles, meta-analyses, editorial comments and studies not fulfilling the inclusion criteria were excluded. In
the selected studies, we also noted any relevant comorbid conditions and autoimmune disorders, therapy used and course of illness.
We obtained written, informed consent from both patients for the publication of the details of their cases.
Case 1
The first patient was a 39-year-old woman who had received a diagnosis of triple-positive APS after a transient ischaemic attack when
she was 26 years old. She presented to hospital with non-resolving occipital headache and right-sided paraesthesia that had started
spontaneously with no preceding trauma or injury. The patient was not on anticoagulation or antiplatelet therapy. She did not have risk
factors for atherosclerosis, was not a smoker or illegal drug user, and had no family history of stroke. On initial evaluation, the National
Institutes of Health Stroke Scale (NIHSS) score was 1, and blood pressure and fundoscopic examination were normal. The chest radiograph,
electrocardiogram, carotid duplex and all blood tests were normal. Brain magnetic resonance imaging (MRI) on admission did not
demonstrate acute infarct or intracranial haemorrhage. Subsequent brain and neck magnetic resonance angiography (MRA) demonstrated
right vertebral artery dissection, with absent contrast flow from the distal V2 segment through the basilar tip (Fig. 1). Warfarin was started
following an initial period of heparin therapy. The patient’s symptoms fully resolved within 48 hours.
Due to the lack of risk factors for arterial dissection, the patient underwent genetic testing for connective tissue disease including Marfan
syndrome and all subtypes of Ehlers-Danlos syndrome. Tests were negative for any genetic mutation associated with connective tissue disease.
Her previous work-up for APS revealed abnormal coagulation studies including a prolonged activated partial thromboplastin time of 40.2
s (normal range 25.1–37.6 s), which did not correct with 1:1 mixing with normal plasma, a thromboplastin inhibition test that was strongly
positive for lupus anticoagulant, and a dilute Russell’s viper venom test that was prolonged at 52.3 s (normal 29–46 s), which corrected with
the addition of phospholipids. Her APS was characterized by substantial levels of immunoglobulin (Ig) G anticardiolipin antibodies (160 IgG
antiphospholipid units (GPLU), reference <20) and IgM anticardiolipin antibodies (23 IgM antiphospholipid units (MPLU), reference <15),
anti-β2 glycoprotein 1 antibodies IgG (150 IgG units (SGU), reference <20) and anti-β2 glycoprotein 1 antibodies IgM (22 IgM units (SGU),
reference <20). The abnormal laboratory findings were confirmed after they were repeated more than 12 weeks apart.

Figure 1. (A, B) Magnetic resonance angiography (MRA) coronal view, and (C) MRA cross-section at the level of C5 showing near occlusion/occlusion of the right vertebral artery with
areas of intraluminal T1 hyperintensity, including an eccentric, circumferential mural focus reflecting intramural haematoma secondary to dissection
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Case 2
The second patient was a 39-year-old woman who had a history of APS that was diagnosed after an episode of unprovoked pulmonary
embolus and recurrent miscarriages. The patient was on anticoagulation treatment with warfarin. She was referred to our centre after
experiencing recurrent spontaneous vertebral artery dissections. She did not have risk factors for atherosclerosis, was not a smoker or
illegal drug user, and did not have a family history of stroke. The first episode was diagnosed after multiple episodes of syncope, paraesthesia
and occipital headache as brain magnetic resonance imaging (MRI) and computed tomography (CT) angiography suggested left vertebral
artery dissection with cerebellar and right posterior cerebral artery (PCA) territory infarcts. These findings were confirmed later with an
angiogram, which demonstrated occlusive dissection of the left vertebral artery at the level of C2. The second event was diagnosed when
the patient was admitted with headache, neck stiffness, nausea, dizziness, blurry vision and aphasia. Brain and neck MRA demonstrated
bilateral vertebral artery dissections. Blood pressure was normal on both admissions.
Testing for rheumatic disease with antinuclear antibody assay and anti-double stranded DNA (anti-dsDNA) was negative, and genetic
testing for connective tissue disorders including Marfan syndrome and all subtypes of Ehlers-Danlos syndrome was also negative.
Previous work-up for APS revealed abnormally high levels of immunoglobulin (Ig) G anticardiolipin antibodies (25, 28 and 23 IgG
antiphospholipid units (GPLU), reference <20) and IgM anticardiolipin antibodies (21, 22 and 19 IgM antiphospholipid units (MPLU),
reference <15) on multiple occasions more than 12 weeks apart. Lupus anticoagulant and anti-β2 glycoprotein 1 antibodies were negative.
DISCUSSION
Arterial dissection occurs when a tear develops in the intimal layer of an artery. Although uncommon, it is a major cause of stroke in young
patients, particularly in the 35–45-year-old age group, and has a predilection for females. It is believed to account for 2.5% of cases of CVA
in the general population and for 5–20% in individuals younger than 45 years of age [5]. Andreoli et al. analysed 120 full-text papers published
in English between the years 1984 and 2011, which showed that approximately 6% of APS patients may develop pulmonary embolism,
13.5% stroke, 11% myocardial infarction, and 9.5% deep venous thrombosis. Many comorbid conditions can precipitate arterial dissection,
such as hypertension, connective-tissue disorders, type IV Ehlers-Danlos syndrome, fibromuscular dysplasia, Marfan syndrome, autosomal
dominant polycystic kidney disease, osteogenesis imperfecta, and the use of oral contraceptives [6, 7].
Many reported cases have suggested a correlation between APS and arterial dissection. Numerous pathophysiological effects of APS may
precipitate dissection development. APS is characterized by a heterogeneous group of antibodies that exert major effects through binding to
the phospholipid membrane of platelets leading to their activation. Moreover, antibodies attach to endothelium, monocytes and neutrophils,
resulting in a hypercoagulability effect. In addition, APS potentiates complement system activation and causes type III hypersensitivity.
Furthermore, in vivo and in vitro studies show that anticardiolipin antibodies have an atherogenic role prompting thickening of the carotid
intima and possibly interfering with wall remodelling in patients with APS. Collectively, these factors increase the risk of coagulation and
vascular alteration [8, 9].
In Table 1, we list cases of dissection in patients diagnosed with APL. The clinical characteristics of the 19 patients identified through the
literature review included young age at dissection detection (average age of 36.68, youngest: 23, oldest: 61 years of age at presentation) and
female preponderance (13 cases, 68.42%). The atherosclerotic vascular risk factors of hypertension, smoking and peripheral artery disease
were seen in three patients (n=3 for each, 15.7%), but other vascular risk factors including diabetes mellitus, dyslipidaemia and illicit drug
abuse, were not found.
Co-existing autoimmune diseases included SLE in five patients (26.3%), Takayasu arteritis in two patients (10.5%), and rheumatoid arthritis,
autoimmune hepatitis and autoimmune hypothyroidism in one patient each (5.2%). The following positive antiphospholipid antibodies were
detected: aCL in 14 patients (73.68%), LAC in 9 patients (47.3%), A-B2GLP in 6 patients (31.5%) and aPE in 1 patient (5.2%). The different
vessels involved included the internal carotid artery, aorta and coronary arteries in four patients each (21.05%), the vertebral artery and
cerebral arteries in three patients (15.7%), and the superficial femoral artery in one patient (5.2%) [10–25].
In this review, we describe two cases of CVA resulting from dissection of the posterior cerebral artery. Both patients met the clinical and
laboratory criteria for APS (Table 2). The first patient was diagnosed with APS after a TIA and confirmed laboratory tests showing triple
positive APS antibodies IgG anticardiolipin antibodies, IgM anticardiolipin antibodies and anti-β2 glycoprotein antibodies IgG confirmed
on multiple occasions 12 weeks apart. The second patient had recurrent miscarriages and positive immunoglobulin IgG anticardiolipin
antibodies and IgM anticardiolipin antibodies on multiple occasions more than 12 weeks apart. Both were diagnosed after other potential
differential diagnoses had been eliminated and potential risk factors excluded [26].
Having obtained detailed histories and conducted physical examinations concurrently with genetic studies and autoimmune disease workup, we theorize that APS might be the cause of the vertebral artery dissections, supported by the absence of atherosclerotic risk factors in
both patients, who were also negative for SLE.
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31/female

34/male

44/female

23/male

61/female

33/female

33/female

None

None

PAD

None

None

None

None

Not mentioned in the
original paper

LAC, IgG aCL
(28.9 GPLU), and
A-B2GLP

No previous
reported

DVT and
pulmonary
embolism

SLE

Takayasu
arteritis

Distal right
coronary artery

Ascending aorta
Stanford type A

Left superficial
femoral artery

LAC, IgG aCL
(>120 GPL/ml) and
antinuclear antibodies

No previous
reported

None

Abdominal aortic
dissection and
rupture

Not mentioned in the
original paper

Left anterior
descending artery

aCL

Recurrent
miscarriage

Chest pain and
shortness of breath

Back pain/
corticosteroids,
immunosuppressive
agents and warfarin,
with ascending aorta
replacement with open
surgical repair

Intermittent
claudication

The patient died after
the rupture

Angina-like symptoms

Angina-like symptoms

Left anterior
descending artery

aCL

Recurrent
miscarriage

Right-sided headache/
NA

Left hemiparesis/
heparin followed with
warfarin

IgG aCL (24 GPLU),IgM Left middle cerebral Aphasia and dizziness/
aPE (0.64 IU/ml)
artery
NA

Right cerebral
artery

Right cerebral
artery

NA/NA

NA/NA

Motor aphasia, right
hemiparesis/IVIG and
IVMP followed by
OACs

(presentation/therapy)

Course of illness

No previous
history

IgG aCL (45 GPLU),
IgM aCL (20 MPLU)

LAC, IgG aCL (50 IU/
ml)

Vertebral artery

Internal carotid
artery

LAC, aCL (21 GPLU),
A-B2GLP (0.7 OD)
LAC, aCL (270 GPLU),
A-B2GLP (0.4 OD)

Internal carotid
artery

Location

IgG aCL (28 GPLU),
IgM aCL (12 MPLU)

Antiphospholipid
antibody status

No previous
history

SLE

None

None

None

Ischaemic stroke

Autoimmune
hepatitis

None

30/female

24/female

Spontaneous
abortion

SLE, Takayasu
arteritis

Hypertension,
smoker and
PAD

36/female

No previous
reported

Reported fetal loss

No previous
reported

Antiphospholipid
attributed
symptoms

None

None

None

Autoimmune
disease

None

26/female

None

Co-morbid
risk factors

41/female

Demographic
(age/gender)
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2019
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Peng et al. [21]

Tatsuoka et al. [22]

Chongprasertpon
et al. [23]

Ulutaş et al. [24]

2021

39/female

39/female

36/female

36/female

39/male

52/male

42/female

29/male

39/female

Demographic
(age/gender)

None

None

None

None

None

None

None

SLE

SLE

History of
tonic-clonic
seizures

Pulmonary
embolism,
recurrent
miscarriage

IgG aCL, IgM aCL

Bilateral vertebral
artery

IgG aCL, IgM aCL, LAC,
Vertebral artery
A-B2GLP

Transient
ischaemic attack

Bilateral vertebral
artery

Bilateral vertebral
artery

Thoracoabdominal
aorta

IgG aCL 24, 32 (IU/ml)

LAC

LAC, IgG aCL

Distal right
coronary artery

Stanford type B
aortic dissection

Left anterior
descending artery

Bilateral internal
carotid artery

Location

No previous
reported

No previous
reported

No previous
reported

Right frontal lobe
infarction, retinal
artery occlusion
and DVT

Autoimmune
hypothyroidism,
rheumatoid
arthritis

Hypertension
and PAD

aCL, A-B2GLP
antinuclear antibody

LAC, aCL and A-B2GLP

Pulmonary
embolism,
abortion less than
24th week

None

Hypertension,
nephropathy

LAC

Antiphospholipid
antibody status

IgG and IgM aCL

None

Smoker,
leukaemia in
remission

Miscarriage at
12th week

Antiphospholipid
attributed
symptoms

No previous
reported

None

Autoimmune
disease

None

Co-morbid
risk factors

Recurrent syncope,
occipital headache and
paraesthesia

Left sided paraesthesia
and headache/heparin
followed by warfarin

Dizziness, gait
disturbance/heparin
followed by warfarin

Visual impairment/
heparin followed by
warfarin

Chest and
abdominal pain/
hydroxychloroquine,
warfarin, steroid,
mycophenolate mofetil
and carbamazepine

Chronic stable angina

Coma due to cerebellar
haemorrhage

Angina-like symptoms

Disturbance of
consciousness, left
hemiparesis/NA

(presentation/therapy)

Course of illness

A-B2GLP, anti-beta 2 glycoprotein; aCL, anti-cardiolipin; aPE, anti-phosphatidylethanolamine; DVT, deep venous thrombosis; GPLU, IgG phospholipid-binding units; IVIG,
intravenous immunoglobin; IVMP, intravenous methylprednisolone; LAC, lupus anticoagulant; MPLU, IgM phospholipid-binding units; NA, not available; OACs, oral anticoagulation drugs; OD, optical density; PAD, peripheral artery disease; SLE, systemic lupus erythematous.
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To the best of our knowledge, we believe these are the first two reported cases of APS patients presenting with PCA ischaemic stroke due to
vertebral dissection who tested negative for SLE. Furthermore, this report adds to the existing literature on vasculopathy and identifies this
area as a subject for further research.

Clinical criteria (at least one of the following):

Laboratory criteria (at least one of the following):

a) Thrombosis: One or more episodes of arterial, venous or small
vessel thrombosis, in any organ or tissue.

a) Positive lupus anticoagulant present in plasma, on two or more
occasions at least 12 weeks apart.

b) Pregnancy morbidity: One of the following:

b) IgG or IgM isotypes of anticardiolipin in serum or plasma, present
in medium or high titre (i.e., >40 IgG phospholipid units and/or
IgM phospholipid units, or >the 99th percentile titre), present on
two or more occasions, at least 12 weeks apart.

1.
One or more unexplained deaths of a morphologically
normal fetus at or beyond the 10th week of gestation, with
normal fetal morphology documented by ultrasound or by direct
examination of the fetus.
2.
One or more premature births of a morphologically normal
neonate before the 34th week of gestation because of: eclampsia
or severe preeclampsia defined according to standard definitions,
or recognized features of placental insufficiency.
3.
Three or more unexplained consecutive spontaneous
abortions before the 10th week of gestation, with maternal
anatomic or hormonal abnormalities and paternal and maternal
chromosomal causes excluded.

c)

IgG or IgM isotypes of anti-beta-2 glycoprotein-I antibody in
serum or plasma (in titre >the 99th percentile), present on two or
more occasions, at least 12 weeks apart.

Table 2. Previously reported cases of arterial dissection in patients diagnosed
with antiphospholipid syndromecircumferential mural focus reflecting intramural
haematoma secondary to dissection

CONCLUSION
The precise mechanism behind vasculopathy and its consequences in patients with APS remains to be clearly defined. Vasculopathy
has manifold presentations such as thrombosis, embolus, cutaneous manifestations, and pregnancy-related morbidity. Moreover, we
demonstrate a potential relationship between APS and arterial dissection. Comorbid risk factors and coexisting autoimmune disease were
present in some cases, which requires further research and study. Finally, the striking presentation of arterial dissection should be kept in
mind by clinicians in patients diagnosed with or suspected of having APS.
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